Mar 18 2020 |
U.S. Senate Will Now Consider Paid Sick Leave and Paid Public Health Emergency Benefits |
Greenberg Traurig, LLP |
Mar 18 2020 |
Risks of Dusting Off the Scrubs |
Wilson Elser Moskowitz Edelman & Dicker LLP |
Mar 18 2020 |
OSHA Offers Employers ‘Guidance on Preparing Workplaces for COVID-19’ |
Jackson Lewis P.C. |
Mar 18 2020 |
#WorkforceWednesday: COVID-19 Pandemic, Election Rules Challenged, EEOC Limits GC’s Authority |
Epstein Becker & Green, P.C. |
Mar 18 2020 |
EPA Will Amend CDR Rule and Extend 2020 Submission Period |
Bergeson & Campbell, P.C. |
Mar 18 2020 |
EEOC Publishes Additional COVID-19 Guidance, Including Confirmation of Employer Ability to Temperature Test under ADA (US) |
Squire Patton Boggs (US) LLP |
Mar 18 2020 |
House Modifications to H.R. 6201, Families First Coronavirus Response Act |
Greenberg Traurig, LLP |
Mar 18 2020 |
Coronavirus (COVID-19) Exemption for Certain Money Manager (Investment Adviser) Filing and Delivery Requirements |
Norris McLaughlin P.A. |
Mar 18 2020 |
Coronavirus and Trade – US Perspective; What Comes Next? |
Squire Patton Boggs (US) LLP |
Mar 18 2020 |
OSHA Issues Temporary Guidance for Health Care Industry Hoping to Blunt Possible Respirator Shortage |
Jackson Lewis P.C. |
Mar 18 2020 |
USCIS Suspends Interviews and Premium Processing for Cap H-1B Cases, Consulates Suspend or Limit Visa Interviews |
Varnum LLP |
Mar 18 2020 |
Benefits Guidance in the Time of COVID-19: Monitoring Retirement Plan Investments and Participant Communications |
Epstein Becker & Green, P.C. |
Mar 18 2020 |
US District Court Orders USDA to Revise Errors Related to Organic Animal Welfare Rule Withdrawal |
Keller and Heckman LLP |
Mar 18 2020 |
Relaxing Of HIPAA Laws During COVID-19 Pandemic |
Barnes & Thornburg LLP |
Mar 18 2020 |
Secretary Azar Waives Certain HIPAA Sanctions and Penalties Against Covered Hospitals |
Davis|Kuelthau, s.c. |
Mar 18 2020 |
A Problem Of Disgorgement |
Allen Matkins Leck Gamble Mallory & Natsis LLP |
Mar 18 2020 |
Episode 8: What’s Ahead for Provider-Focused Health Care Investing? [PODCAST] |
Foley & Lardner LLP |
Mar 18 2020 |
Coronavirus Prompts Telehealth Changes For Medicare |
Barnes & Thornburg LLP |
Mar 18 2020 |
HHS Removes Enforcement Barriers for Telehealth during COVID-19 Nationwide Public Health Emergency |
Jackson Lewis P.C. |
Mar 18 2020 |
OSHA Guidance on Respirator Fit-Testing in Health Care During COVID-19 Outbreak |
Foley & Lardner LLP |
Mar 18 2020 |
Coronavirus Challenges for Commercial Landlords |
Davis|Kuelthau, s.c. |
Mar 18 2020 |
CMS/HHS Issues FAQs on Essential Health Benefits and COVID-19 |
Hill Ward Henderson |
Mar 18 2020 |
Section 1135 Waivers Now Available, But Some Waivers May Require Approval |
McDermott Will & Schulte LLP |
Mar 18 2020 |
FDA Issues Final Guidance On Third-Party Review Of 510(K) Applications |
Barnes & Thornburg LLP |
Mar 18 2020 |
Legal Implications for Telecommuting / Working from Home in Response to the Coronavirus |
Hill Ward Henderson |
Mar 17 2020 |
Lenders Encouraged to Work with Customers in Response to COVID-19 Challenges |
Sheppard, Mullin, Richter & Hampton LLP |
Mar 17 2020 |
BitBlog Bi-Weekly Update: MARCH 17, 2020 |
Polsinelli PC |
Mar 17 2020 |
Government Significantly Expands Telehealth Reimbursement During COVID-19 Public Health Emergency |
Robinson & Cole LLP |
Mar 17 2020 |
Bipartisan Congress Intensifies Efforts to Restrict Orphan Drug Exclusivity |
Proskauer Rose LLP |
Mar 17 2020 |
Technical Corrections to the House’s Employment Provisions within the Families First Coronavirus Response Act |
Foley & Lardner LLP |
Mar 17 2020 |
How to Navigate the Coronavirus: A Reference Guide for Employers |
Wilson Elser Moskowitz Edelman & Dicker LLP |
Mar 17 2020 |
TRICARE Autism Care Demonstration Program Changes – Summer 2020 |
Epstein Becker & Green, P.C. |
Mar 17 2020 |
Talking about The Thing |
Squire Patton Boggs (US) LLP |
Mar 17 2020 |
Congress’s COVID-19 Funding Legislation Expands Access to Telehealth Services for Medicare Beneficiaries |
Epstein Becker & Green, P.C. |
Mar 17 2020 |
Takeaways from Recent Remarks on the DOJ Antitrust Leniency Program |
Proskauer Rose LLP |